c-Myc tag Peptide: Precision Reagent for Transcription Factor and Immunoassay Control

Executive Summary: The c-Myc tag Peptide (A6003) from APExBIO is a synthetic peptide matching the C-terminal residues 410–419 of human c-myc, designed for competitive displacement of c-Myc-tagged fusion proteins in immunoassays (APExBIO product page). This reagent facilitates specific anti-c-Myc antibody binding inhibition, critical for accurate immunoassay interpretation and troubleshooting (Wu et al., 2021). c-Myc is a well-established proto-oncogene encoding a transcription factor that orchestrates cell proliferation, apoptosis, and differentiation. The c-Myc tag Peptide is highly soluble (≥60.17 mg/mL in DMSO; ≥15.7 mg/mL in water with sonication), but insoluble in ethanol, and must be stored desiccated at -20°C for maximum stability. This article details its biological rationale, mechanism, evidence base, application boundaries, workflow integration, and future prospects.

Biological Rationale

c-Myc is a nuclear transcription factor encoded by the MYC proto-oncogene. It regulates genes involved in cell cycle progression, growth, metabolism, apoptosis, and stem cell self-renewal (Wu et al., 2021). Aberrant c-Myc activity is implicated in the pathogenesis of many cancers via gene amplification, chromosomal translocation, or dysregulated transcription (Advanced Mechanisms). The c-Myc tag Peptide, derived from the C-terminal 10 amino acids of the human c-Myc protein, is commonly used as an epitope tag for recombinant protein expression. It enables detection and purification using anti-c-Myc antibodies (Innovations in Transcription Factor Analysis). The peptide itself acts as a competitive inhibitor that can specifically displace c-Myc-tagged proteins from antibody complexes, permitting controlled elution or validation of antibody specificity (Precision Displacement). This approach is crucial for accurate immunoassay performance and for dissecting dynamic protein–protein or protein–DNA interactions involving c-Myc.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide (sequence: EQKLISEEDL) mimics the epitope recognized by monoclonal anti-c-Myc antibodies. When introduced to a system containing c-Myc-tagged fusion proteins, the synthetic peptide competes for antibody binding, effectively displacing the tagged proteins from the antibody complex (Wu et al., 2021; APExBIO). This displacement is stoichiometric and reversible, enabling precise modulation of immunoassay signal and specificity. The approach is particularly valuable in applications such as western blotting, immunoprecipitation, chromatin immunoprecipitation (ChIP), and ELISA, where non-specific binding or cross-reactivity can confound results (Next-Generation Insights). The c-Myc tag Peptide’s high solubility in DMSO and water (with sonication) ensures compatibility with various assay buffers and conditions. Insolubility in ethanol and susceptibility to degradation in solution underscore the need for careful storage and handling (desiccated, -20°C).

Evidence & Benchmarks

• The c-Myc tag Peptide (A6003) displaces c-Myc-tagged fusion proteins from monoclonal anti-c-Myc antibody complexes in immunoassays, validating antibody specificity (APExBIO).
• c-Myc protein regulates expression of cyclins and ribosomal proteins, promoting cell proliferation and growth (Wu et al., 2021).
• Disruption of c-Myc activity induces cell cycle arrest and apoptosis via upregulation of p21 and downregulation of Bcl-2 (Wu et al., 2021).
• The peptide is highly soluble at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (with ultrasound); insoluble in ethanol (APExBIO).
• Specific displacement is reversible and does not affect endogenous c-Myc function in live-cell systems, when used at recommended concentrations (Precision Displacement).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is widely used in molecular biology, protein chemistry, and cancer research.

• Immunoassay Control: Enables precise elution of c-Myc-tagged proteins from antibody matrices during immunoprecipitation or affinity purification workflows.
• Antibody Validation: Distinguishes specific from non-specific anti-c-Myc antibody binding in complex lysates.
• Transcription Factor Research: Facilitates mechanistic studies on c-Myc-mediated gene amplification and proto-oncogene function (Advanced Mechanisms).
• Experimental Therapeutics: Serves as a tool for dissecting signaling pathways involving c-Myc and related transcription factors.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not inhibit endogenous c-Myc transcription factor function in live cells at experimental concentrations.
• It is not suitable for diagnostic or medical use; it is research-only (APExBIO).
• Peptide solutions lose activity if stored long-term at room temperature or in aqueous solution; always store desiccated at -20°C.
• Not effective for displacement in systems using non-canonical myc tag sequences.
• Performance may vary with antibody isotype and vendor; empirical optimization is required.

This article extends prior work by providing updated solubility benchmarks and clarifying peptide use boundaries, building upon discussions in Innovations in Transcription Factor Analysis and Precision Displacement.

Workflow Integration & Parameters

The c-Myc tag Peptide is supplied as a lyophilized powder. For maximal solubility, dissolve at concentrations up to 60.17 mg/mL in DMSO, or 15.7 mg/mL in water with ultrasound. Avoid ethanol as a solvent due to insolubility. Recommended storage is desiccated at -20°C; avoid repeated freeze-thaw cycles and prolonged aqueous storage. In immunoprecipitation or western blotting, add the peptide at a 10–100 fold molar excess over the estimated c-Myc-tagged protein load. Empirical titration may be necessary to optimize displacement efficiency based on antibody affinity and sample complexity. For best results, prepare fresh peptide solutions before each use. For further troubleshooting strategies, see Strategic Deployment, which this article updates by providing quantitative solubility parameters and recent mechanistic insights.

Conclusion & Outlook

The c-Myc tag Peptide (A6003, APExBIO) is a validated, highly specific reagent for displacing c-Myc-tagged fusion proteins in a range of immunoassay applications. Its precise mechanism and robust solubility profile make it an essential tool for research on transcription factor regulation, cancer biology, and the molecular underpinnings of proto-oncogene function. Ongoing advances in autophagy and transcription factor biology may further expand its role in dissecting signal transduction and gene regulation. For comprehensive guidance, refer to the product page and recent reviews on c-Myc tag Peptide applications.